p53 protein accumulation and p53 gene mutation in esophageal carcinoma
Open Access
Abstract
BACKGROUND p53 gene mutation and p53 protein accumulation are common in human cancer. However, their clinical significance is controversial and p53 accumulation may not correlate with gene mutation. The current study investigates the occurrence of p53 alterations in esophageal carcinoma, the correlation between the analyses at the gene and protein level, and their prognostic significance. METHODS A series of 74 esophageal carcinomas (46 squamous cell carcinomas, 21 Barrett's adenocarcinomas, and 7 undifferentiated carcinomas) was studied by single strand conformation polymorphism (SSCP) analysis and immunohistochemistry (IHC) to detect p53 mutation and accumulation, respectively. RESULTS p53 mutations in exons 5‐8 were detected in 53% of the carcinomas whereas p53 accumulation was observed in 57% of cases. Comparing SSCP and IHC, there were 27 discordant cases (38%). Overall, only 20 tumors (27%) did not display p53 mutation and/or p53 accumulation. No associations were found between p53 aberrations and clinicopathologic parameters, including patients' age and gender, tumor type, stage, and grade. p53 protein accumulation and p53 gene mutation were not related to patient survival by univariate or multivariate analysis in esophageal carcinomas. CONCLUSIONS p53 aberrations are very common in esophageal carcinomas. However, p53 gene mutation and p53 protein accumulation have a significant discordance, suggesting that p53 function may be inactivated by mechanisms other than mutation. p53 aberrations do not independently predict prognosis in esophageal tumors. Cancer 1997; 79:425‐32. © 1997 American Cancer Society.Keywords
This publication has 33 references indexed in Scilit:
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI: Journal of the National Cancer Institute, 1996
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapyNature Medicine, 1995
- High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosisCancer, 1994
- P53 protein expression and prognosis in squamous cell carcinoma of the esophagusCancer, 1994
- The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesisBritish Journal of Cancer, 1994
- p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: A follow-up studyGastroenterology, 1993
- Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinomaVirchows Archiv, 1993
- Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.Proceedings of the National Academy of Sciences, 1993
- Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.Proceedings of the National Academy of Sciences, 1991
- Frequent mutation of the p53 gene in human esophageal cancer.Proceedings of the National Academy of Sciences, 1990